CD146: a promising target in respiratory diseases

Area of Science:

• Biomedical research
• Pulmonary medicine
• Vascular biology

Background:

• Respiratory diseases cause significant global mortality and morbidity.
• Vascular mechanisms are critical in the pathogenesis of lung diseases.
• Identifying novel biomarkers and therapeutic targets for lung vascularization and angiogenesis is essential.

Purpose of the Study:

• To review the role of CD146 and soluble CD146 (sCD146) in respiratory disease pathogenesis.
• To evaluate CD146/sCD146 as potential biomarkers for lung diseases.
• To explore CD146/sCD146 as therapeutic targets for respiratory conditions.

Main Methods:

• Literature review of studies on CD146/sCD146 in lung diseases.
• Analysis of the involvement of CD146/sCD146 in angiogenesis and inflammation.
• Synthesis of evidence regarding protective and detrimental roles of CD146/sCD146.

Main Results:

• CD146 is an endothelial cell adhesion molecule with a soluble form, sCD146, detectable in biological fluids.
• CD146/sCD146 participate in angiogenesis and inflammation, processes central to many diseases.
• Existing research presents conflicting evidence on the specific roles of CD146/sCD146 in lung pathologies.

Conclusions:

• CD146 and sCD146 show potential as mechanistic biomarkers in respiratory diseases.
• Targeting CD146/sCD146 may offer new therapeutic strategies for lung pathologies.
• Further research is warranted to fully elucidate and validate the role of CD146/sCD146 in respiratory disease treatment.